01
Biofluid collection
Accessible biological samples, such as blood-derived plasma and serum, are the starting point of our investigations.
Our technology
We develop advanced biomarker technologies that turn accessible biological samples into meaningful molecular information, by studying extracellular vesicles (EVs) isolated from biofluids.

Biofluids
Biological fluids contain extracellular vesicles that carry molecular information from many different cells and tissues.
By accessing these signals, MedPrecis aims to bridge the gap between molecular mechanisms and clinically relevant biological information.
Our platform profiles biologically relevant EV populations (including, but not limited to, brain-derived vesicles) combining selective enrichment with protein and microRNA analysis.
From brain to blood
Brain cells (neurons, astrocytes and microglia) continuously release extracellular vesicles. Some of them cross the blood–brain barrier and circulate in the blood.
Each vesicle carries proteins, microRNA and markers of the cell it came from: a molecular snapshot of brain biology, from a simple blood sample.
At a glance
Released by cells throughout the body, extracellular vesicles reflect the state of the tissues they come from.
Our approach (from biofluid sample to vesicle enrichment, protein and microRNA analysis and interpretation) supports research in psychiatry, neurodegeneration, oncology and systemic health.
From sample to insight
A simple, four-stage approach that turns a biofluid sample into interpretable molecular information.
01
Accessible biological samples, such as blood-derived plasma and serum, are the starting point of our investigations.
02
Our proprietary workflow enriches biologically relevant vesicle populations from the sample.
03
Vesicle-associated proteins and microRNAs are analysed together for complementary information on disease-related pathways.
04
Results support the study of biological mechanisms, biomarker signatures and differences between patients.
Our scientific advantage
Access molecular signals associated with specific tissues and cell populations through enriched vesicles.
Study the biological pathways involved in disease, beyond conventional clinical classifications alone.
Combine complementary protein and microRNA information to explore disease-associated molecular signatures.
Structured procedures and quality-control practices designed for reliable, traceable measurements.
Applications
Identify and investigate molecular signatures associated with disease states and biological processes.
Explore biologically informed patient subgroups to support precision-oriented research.
Support exploratory and translational biomarker studies within clinical research programmes.
Investigate disease mechanisms and molecular responses to therapeutic interventions.
Scientific foundation
MedPrecis builds on research connecting molecular mechanisms, extracellular-vesicle biology and human disease.
Our technology is supported by research expertise, scientific publications and collaborations with academic and clinical institutions.
We aim to translate advances in molecular neuroscience into scalable biomarker applications for research and therapeutic development.
Partner with MedPrecis
We work with pharmaceutical companies, biotech innovators, academic institutions and clinical research teams to advance biomarker-driven research.
Whether you are planning a clinical study, investigating therapeutic mechanisms or exploring new biomarker strategies, we can contribute specialised analytical expertise.
Further validated assay specifications and performance characteristics can be shared with collaborators where needed for reproducibility, while protecting our proprietary technology.